Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Astragalus and Cinnamon Twig Decoction for Post-Chemotherapy Peripheral Neuropathy
NCT07891403Phase 2Completed
- Sponsor
- Emeishan Hospital of Traditional Chinese Medicine
- Start
- May 2025
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Phase 2, randomised trial in chemotherapy-induced peripheral neuropathy (CIPN) (2 arms), sponsored by Emeishan Hospital of Traditional Chinese Medicine. Primary endpoints: Patient Experience at month 1, Chemotherapy-Induced Peripheral Neuropathy Grading Criteria at month 1 and 2 more. Started May 2025; status: completed.
02
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT07891403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07891403.